EE223 Estimation of the T-Cell Engagers (Bi-Specific Monoclonal Antibodies and Chimeric Antigen Receptor [CAR T-CELL]) Therapy Administration Pathways From French Hospitals and National Health Insurance Perspective and Financial Impact
Abstract
Authors
C. Le Dissez K. Le Lay G. Cartron R. El Machhour N. Baillon R.M. Ferri